Home > Cashflow Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹2,585 Cr₹3,266 Cr₹2,368 Cr₹1,803 Cr₹2,005 Cr

What is the latest Cash Flow from Operating Activities ratio of TORRENT PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of TORRENT PHARMACEUTICALS is ₹2,585 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹2,585 Cr
Mar2024₹3,266 Cr
Mar2023₹2,368 Cr
Mar2022₹1,803 Cr
Mar2021₹2,005 Cr

How is Cash Flow from Operating Activities of TORRENT PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹2,585 Cr
-20.85
Mar2024 ₹3,266 Cr
37.92
Mar2023 ₹2,368 Cr
31.34
Mar2022 ₹1,803 Cr
-10.09
Mar2021 ₹2,005 Cr -

Compare Cash Flow from Operating Activities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹147,907.9 Cr -0% 10% 45.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,704.0 Cr 3.1% 6.2% 13.5% Stock Analytics
DIVIS LABORATORIES ₹168,223.0 Cr -1% 3.3% 14.2% Stock Analytics
DR REDDYS LABORATORIES ₹107,368.0 Cr -0.6% 3.3% 16.4% Stock Analytics
CIPLA ₹107,043.0 Cr -2% -0.6% -6.1% Stock Analytics
MANKIND PHARMA ₹89,250.5 Cr -3.7% 3.8% -5.9% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-0%

10%

45.6%

SENSEX

-4.6%

-7.5%

6%


You may also like the below Video Courses